In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE)

Magnetic Resonance Imaging

Volumn 21, Issue 9, 2003, Pages 1033-1037

  Handa, R ^a   Sahota, P ^a   Kumar, M ^a   Jagannathan, N R ^a   Bal, C S ^a   Gulatid, M ^a   Tripathi, B M ^a   Wali, J P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Magnetic resonance spectroscopy; Single photon emission computerized tomography; Systemic lupus erythematosus

Indexed keywords

ADULT; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; IMAGING SYSTEM; IN VIVO STUDY; MALE; NEUROIMAGING; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0346118794     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(03)00200-5     Document Type: Article

References (31)

1. West SG. Neuropsychiatric lupus. Rheum Dis Clin North Am 1994;20:129-58.
2. Ward MM, Pyun E, Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch Int Med 1996;156:1337-44.
3. Sibbitt WL, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999;42:2026-38.
4. West SG, Emlen W, Wener MH, Kotzin BL. Neuropsychiatric lupus erythematosus: a 10-year prospective study on the value of diagnostic tests. Am J Med 1995:99:153-63.
5. [51 McCune WJ, MacGuire A, Aisen A, Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum 1988;31:159-66.
6. Jarek MJ, West SG, Baker MR, Rak KM. Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus. Arthritis Rheum 1994;37:1609-13.
7. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
8. [81 The Committee on prognosis studies in SLE, Bombardier C, Gladman DD, Urowitz M, Caron D, Chang C. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
9. Frahm J, Merboldt KD, Hanicke W. Localized proton spectroscopy using stimulated echoes. J Mag Reson 1987;72:502-8.
10. Raymond AA, Zariah AA, Samad SA, Chin CN, Kong NC. Brain calcification in patients with cerebral lupus. Lupus 1996;5:123-8.
11. Reiff A, Miller J, Shaham B, Bernstein B, Szer IS. Childhood central nervous system lupus: longitudinal assessment using single photon emission computed tomography. J Rheumatol 1997;24:2461-5.
12. Shapeero LG, Norman A. Imaging of systemic lupus erythematosus. In: Lahita RG, editor. Systemic lupus erythematosus. 2nd ed. New York: Churchill Livingstone. 1992. p. 477-526.
13. Aisen AM, Gabrielsen TO, McCune WJ. MR imaging of systemic lupus erythematosus involving the brain. Am J Roentgenol 1985;144:1027-31.
14. Stoppe G, Wildhagen K, Seidel JW, Meyer GJ, Scheber O, Heintz P, et al. Position emission tomography in neuropsychiatric lupus crythematosus. Neurology 1990;40:304-8.
15. Chia-Hung, Yung-Jen H, Jung-Liang L, Sheng-K Ping C, Ko-Kaung L, Poon-Ung C. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999;42:61-8.
16. Hachulla E, Michon-Pasturel U, Leys D, Pruvo JP, Queyvrel V, Masy E, et al. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 1998;7:124-31.
17. Lin WY, Wang SJ, Ten TC, Lan JL. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 1997;38:1112-5.
18. Colamussi P, Giganti M, Cittanti C, Dovigo L, Trotta F, Tola MR, et al. Brain single photon emission tomography with 99m Tc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995;22:17-24.
19. Emmi L, Bramati M, de Cristofaro MT, Mascalchi M, dal Pozzo G, Marconi GP, et al. MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 1993;11:13-20.
20. Nossent JC, Hovestadt A, Schonfeld DH, Swaak AJ. Single photon emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991;34:1397-403.
21. Fein G, Meyerholf DJ, DiSclafani V, Ezekiel F, Poole N, Mackay S, Dillon WP, Constans JM, Weiner MW. Proton MRS separates neuronal from glial changes in alcohol-related brain atrophy. In: Alcohol and Glial Cell. Research Monograph 27, National Institutes of Health, Bethesda, MD, 1994:227-241.
22. Jagannathan NR, Desai NG, Raghunathan P. Brain metabolite changes in alcoholism: An in-vivo proton MRS study. Magn Reson Imaging 1996;14:553-7.
23. 1H magnetic resonance spectroscopy of the brain in detecting early normal damage in systemic lupus erythematous. Ann Rheum Dis 2001;60:106-111.
24. Falini A, Calabrese G, Filippi M, et al. Benign versus secondary-progressive multiple sclerosis: the potential role of proton MR spectroscopy in defining the nature of disability. Am J Neuroradiol 1998;19:223-9.
25. 1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry 1997;63:736-42.
26. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transaction in the lesions of multiple sclerosis. New Engl J Med 1998;338:278-85.
27. Degaonkar MN, Khubchandani M, Dhawan JK, Jayasundar R, Jagannathan NR. Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model. NMR Biomed 2002;15:293-300.
28. Brooks WM, Jung RE, Ford CC, Greinel EJ, Sibbitt WL. Relationship between neurometabolic derangement and neurocognitive dysfunction in systemic lupus erythematosus. J Rheumatol 1999;26:81-5.
29. Brenner RE, Munro PM, Williams SC, et al. The proton MR spectrum in acute EAE: the significance of the change in Cho: Cr ratio. Magn Reson Med 1993;29:737-45.
30. Soher RJ, van Zijl PC, Duyn JH, Backer PB. Quantitative proton MR spectroscopic imaging of human brain. Magn Reson Med 1996;35:356-63.
31. [311 Sibbitt WL, Haseler LJ, Griffey RR, Friedman SD, Brooks WM. Neurometabolism of active neuropsychiatric lupus determined with proton MR spectroscopy. Am J Neuroradiol 1997;18:1271-7.